Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 3, 2006, Pages 522-526

  Ishida, Kazuya ^a   Takaai, Mari ^a   Hashimoto, Yukiya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Caco 2 cell monolayer; Intestinal absorption; Levofloxacin; Quinidine; Tertiary amine

Indexed keywords

CARNITINE; CARVEDILOL; DIGITONIN; DIPHENHYDRAMINE; LEVOFLOXACIN; QUINIDINE; RIFAMYCIN;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE; CELL PH; CONTROLLED STUDY; DRUG ABSORPTION; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; INTRACELLULAR TRANSPORT; LOW TEMPERATURE; TEMPERATURE SENSITIVITY;

ALGORITHMS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; DRUG INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; QUINIDINE; TEMPERATURE;

EID: 33645212259     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.522     Document Type: Article

References (20)

1. Vaughan Williams E. M., J. Clin. Pharmacol., 24, 129-147 (1984).
2. Grace A. A., Camm A. J., N. Engl. J. Med., 338, 35-45 (1998).
3. Ueda C. T., Williamson B. J., Dzindzio B. S., Clin. Pharmacol. Ther., 20, 260-265 (1976).
4. Ochs H. R., Greenblatt D. J., Woo E., Clin. Pharmacokinet., 5, 150-168 (1980).
5. Nielsen T. L., Rasmussen B. B., Flinois J. P., Beaune P., Brøsen K., J. Pharmacol. Exp. Ther., 289, 31-37 (1999).
6. Thompson K. A., Blair I. A., Woosley R. L., Roden D. M., J. Pharmacol. Exp. Ther., 241, 84-90 (1987).
7. Bauer L. A., "Applied Clinical Pharmacokinetics," Chap. 9, ed. by Zollo S., Edmonson K. G., Shimer S., Ruzycka R., O'Connor J., Baker C., McGraw-Hill, New York, 2001, pp. 405-438.
8. Mizuuchi H., Katsura T., Saito H., Hashimoto Y., Inui K., J. Pharmacol. Exp. Ther., 290, 388-392 (1999).
9. Mizuuchi H., Katsura T., Ashida K., Hashimoto Y., Inui K., Am. Physiol. Gastrointest. Liver Physiol., 278, G563-G569 (2000).
10. Hidalgo I. J., Raub T. J., Borchadt R. T., Gastroenterology, 96, 736-749 (1989).
11. Artursson P., J. Pharm. Sci., 79, 476-482 (1990).
12. Artursson P., Karlsson J., Biochem. Biophys. Res. Commun., 175, 880-885 (1991).
13. Aiba T., Ishida K., Yoshinaga M., Okuno M., Hashimoto Y., Biol. Pharm. Bull., 28, 114-119 (2005).
14. Violini S., Sharma V., Prior J. L., Dyszlewski M., Piwnica-Worms D., Biochemistry, 41, 12652-12661 (2002).
15. Takara K., Kakumoto M., Tanigawara Y., Funakoshi J., Sakaeda T., Okumura K., Life Sci., 70, 1491-1500 (2002).
16. Vavricka S. R., Van Montfoort J., Ha H. R., Meier P. J., Fattinger K., Hepatology, 36, 164-172 (2002).
17. Elimrani I., Lahjouji K., Seidman E., Roy M. J., Mitchell G. A., Qureshi I., Am. J. Physiol. Gastrointest. Liver Physiol., 284, G863-G871 (2003).
18. Yamaguchi H., Yano I., Saito H., Inui K., Eur. J. Pharmacol., 431, 297-303 (2001).
19. Hunter J., Jepson M. A., Tsuruo T., Simmons N. L., Hirst B. H., J. Biol. Chem., 268, 14991-14997 (1993).
20. Fromm M. F., Kim R. B., Stein M., Wilkinson G. R., Roden D. M., Circulation, 99, 552-557 (1999).